The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

Not specified

Study Completion Date

September 30, 1996

Conditions
HIV Infections
Interventions
DRUG

Interferon alfa-2a

DRUG

Zidovudine

Trial Locations (9)

10016

NYU Med. Ctr., Dept. of Medicine, New York

38105

St. Jude/UTHSC CRS, Memphis

60612

Cook County Hosp., Chicago

60614

Chicago Children's CRS, Chicago

70112

Tulane/LSU Maternal/Child CRS, New Orleans

02118

BMC, Div. of Ped Infectious Diseases, Boston

Unknown

Univ. Hosp. Ramón Ruiz Arnau, Dept. of Peds., Bayamón

00936

San Juan City Hosp. PR NICHD CRS, San Juan

Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS, San Juan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Glaxo Wellcome

INDUSTRY

collaborator

Hoffmann-La Roche

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000967 - The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children | Biotech Hunter | Biotech Hunter